Immobility of patients in medical and orthopaedic departments. A German-wide survey.

[1]  L. Norgren,et al.  Incidence of deep vein thrombosis in bedridden non-surgical patients. , 2009, Acta medica Scandinavica.

[2]  C. Diehm,et al.  Leitlinien zur Thromboseprophylaxe in der Orthopädie , 2008 .

[3]  V. Bagaria,et al.  Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study , 2006, Postgraduate Medical Journal.

[4]  M. Prins,et al.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial , 2006, BMJ : British Medical Journal.

[5]  G. Lip,et al.  Antithrombotic therapy for congestive heart failure , 2005, International journal of clinical practice.

[6]  C. Colwell,et al.  Prevention of venous thromboembolism. , 1994, Chest.

[7]  L. Passos,et al.  Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. , 2005, Chest.

[8]  Clifford W Colwell,et al.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[9]  S. Goldhaber,et al.  Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients , 2004, Circulation.

[10]  F. Piette,et al.  Risk Factors for Deep Vein Thrombosis in Inpatients Aged 65 and Older: A Case‐Control Multicenter Study , 2004, Journal of the American Geriatrics Society.

[11]  L. Kinzl,et al.  [Stationary thromboprophylaxis in casualty surgery. Relevance of postoperative mobility and preexisting risk factors]. , 2004, Der Unfallchirurg.

[12]  L. Rabbani,et al.  A Rationale for the Use of Anticoagulation in Heart Failure Management , 2004, Journal of Thrombosis and Thrombolysis.

[13]  S. Goldhaber,et al.  A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. , 2004, The American journal of cardiology.

[14]  A. Turpie,et al.  Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[15]  A. Turpie,et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. , 1999, The New England journal of medicine.

[16]  C. Trivalle,et al.  [Use of low molecular weight heparin for medical prophylaxis by European geriatricians]. , 2006, La Revue de medecine interne.

[17]  C. Trivalle,et al.  Utilisation des héparines de bas poids moléculaire en prévention médicale par les gériatres européens , 2006 .

[18]  F. Stammler,et al.  [Guidelines for prevention of thrombosis in orthopedics]. , 1998, Zeitschrift fur Orthopadie und ihre Grenzgebiete.